Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • Chapter 6 - The Socioeconomic Costs of Mood Disorders

  • Edited by Allan Young, Institute of Psychiatry, King's College London, Marsal Sanches, Baylor College of Medicine, Texas, Jair C. Soares, McGovern Medical School, The University of Texas, Mario Juruena, King's College London
  • Book:
    Clinical Textbook of Mood Disorders
    Published online:
    16 May 2024
    Print publication:
    23 May 2024, pp 68-73

  • Summary

    Patients with mood disorders experience substantial challenges in their lives, often over long-term periods and despite receiving treatment. Provision of clinical care for mood disorders involves direct monetary costs. Illness also leads to indirect socioeconomic costs due to reduced work capacity. The absence of these patients from wider economic activity within society is another indirect cost. Estimating the impact of mood disorders in monetary terms mainly relies on administrative records, patient surveys, and mathematical models. Although estimations may vary between studies depending on methodology, annual economic cost of major depressive disorder and bipolar disorder in the UK may exceed £8 billion and £7 billion, respectively, with the majority of this cost accounted for by lost production rather than provided healthcare. Other indirect costs are commonly ignored and require further research. Cost of illness studies may serve as the basis for economic evaluations (e.g., cost-effectiveness analyses) of interventions targeting mood disorders.